The risk of developing myocarditis among males ages 16 to 19 years are about one in 15,000 after the third dose of the Pfizer-BioNTech Covid-19 vaccine, however the cases are rare and mild, according to a new research conducted in Israel.
Myocarditis is the inflammation of the middle layer of the wall of the heart muscle, the myocardium. The condition is uncommon and may temporarily or permanently weaken the heart muscle and the heart's electrical system, which keeps the heart beating.
"It is important to understand the connections between this rare heart condition and Covid-19 vaccines, so we can monitor the prevalence of myocarditis and pay extra attention to those who are most at risk,a said lead study author Dror Mevorach, chairman of the Israeli Ministry of Health Committee for 'Identifying Myocarditis as an Adverse Effect of mRNA Vaccines' in Jerusalem.
Before the pandemic, it was estimated that approximately 10 to 20 people per 100,000 were diagnosed with myocarditis each year, according to the American Heart Association (AHA).
The incidence rate of post-vaccination myocarditis in Israel was relatively low but primarily in young males after a second Covid-19 vaccination, suggesting a potential relationship between the vaccine and myocarditis, according to the research published by the country's Ministry of Health.
The risk differences declined significantly between the second and third vaccine doses across both genders and across all age groups.
The researchers said that the first explanation is that individuals who developed myocarditis after the second Covid-19 vaccine dose did not receive a third shot, as per the medical precaution in Israel.
"The second potential explanation is the interval of time between doses: first and second doses are administered approximately three weeks apart, however, the time between a second dose and a booster was about 20 to 24 weeks," said Mevorach.
Researchers believe further study is required to better explain what may predispose young males to develop myocarditis after a Covid-19 vaccine and the pathophysiological mechanisms involved.
New immunotherapy to fight cancer, keep healthy cells safe
A team of US researchers has developed a new immunotherapy technique that uses cytokine proteins as a potential treatment, effectively targeting tumours without causing harm to healthy cells.
Why excess sugar, oil are as dangerous for liver as alcohol
While alcohol is known to be bad for liver health, consuming foods rich in sugar and oil may be equally dangerous for the organ as well as for overall health, said doctors on Thursday, ahead of World Liver Day.
Lungs of young adults more susceptible to SARS-CoV-2 virus: Study
While older age has been associated with an increased risk of SARS-CoV-2, the virus responsible for Covid-19, a new study has revealed that the lungs of young adults are more susceptible to the virus.
This vaccine helped over 50 pc of people remain UTI-free for years
More than 50 per cent of people remained Urinary Tract Infection (UTI)-free for up to nine years who received the oral spray-based vaccine 'MV140', a new study has said.
Congress in Tripura blocks rail stations to protest police fired-killing of 5 farmers in MP
The firing on Tuesday came during raucous protests to demand better crop prices in the drought-ravaged region that saw one farmer suicide every five hours in the past two years.
DMs, SPs of violence-hit MP districts transferred
The farmers agitation entered its eighth day on Thursday. The peasants have been on strike since June 1, demanding loan waiver and fair price for their produce.
Indian American selected among 12 NASA astronaut candidates
He continued on to earn a master's degree in aeronautics and astronautics from Massachusetts Institute of Technology and graduated from the US Naval Test Pilot School.
World's oldest human species' fossils found in Morocco
The institute said the remains of the Homo sapiens, which were found in a remote village called Jbel Irhoud, date back to over 300,000 years ago, Xinhua reported.